What is the diagnosis of choledocholithiasis, its typical presenting complaint, clinical presentation and examination findings, and what is the gold‑standard imaging test (including the role of a full blood count)?

Diagnosis of Choledocholithiasis

Choledocholithiasis should be diagnosed using MRCP or EUS as the gold standard imaging modalities, not ultrasound or FBC, with the choice between them based primarily on local availability and patient factors rather than diagnostic superiority. 1

Common Presenting Complaints

The typical patient presents with:

• Right upper quadrant abdominal pain (present in approximately 96% of cases), often colicky in nature and may radiate to the right shoulder or supraclavicular region 2, 3
• Jaundice when obstruction is significant, particularly when combined with pain and duct dilatation in patients with known gallstone history 1
• Nausea and vomiting are frequently reported accompanying symptoms 2
• Features of cholangitis (fever, jaundice, right upper quadrant pain) represent high-risk presentations requiring urgent intervention 1, 4

Clinical Examination Findings

Physical examination may reveal:

• Positive Murphy's sign (pain on palpation of the right upper quadrant during deep inspiration) 2
• Jaundice on inspection if bilirubin is significantly elevated 1
• Fever and hemodynamic instability in cases complicated by cholangitis 4
• Important caveat: Lack of physical examination findings does NOT rule out choledocholithiasis 2

Laboratory Testing (FBC and Beyond)

A full blood count is not the diagnostic test of choice, but laboratory evaluation plays an important supportive role:

• Elevated total bilirubin (particularly >4 mg/dL or even 1.8-4 mg/dL) is a significant predictor 5, 6
• Abnormal liver biochemical tests including elevated liver enzymes help stratify risk 5, 6
• White blood cell count may be elevated, especially in cholangitis 2
• Amylase and lipase should be checked to identify concurrent gallstone pancreatitis 2, 5

These laboratory values are used for risk stratification rather than definitive diagnosis 1, 5, 6

Gold Standard Imaging

Primary Diagnostic Imaging

MRCP and EUS are equivalent gold standards with comparable diagnostic performance:

• MRCP sensitivity: 93% and specificity: 96% 1
• EUS sensitivity: 95% and specificity: 97% 1
• Neither test demonstrates clear superiority when the same patients undergo both modalities 1

Choosing Between MRCP and EUS

MRCP is generally preferred as the first-line test because it is:

• Widely available 1
• Minimally invasive 1
• Able to image intrahepatic ducts 1
• More cost-effective 1
• Suitable for patients with altered gastric/duodenal anatomy 1
• Allows image capture for later review by other clinicians 1

EUS should be chosen when:

• Patient has intracranial metallic clips, cardiac pacemakers, or mechanical heart valves 1
• Severe claustrophobia prevents MRCP 1
• Morbid obesity limits MRCP quality 1
• Appropriately skilled endoscopists are available 1

Role of Other Imaging

• Transabdominal ultrasound is NOT the gold standard for choledocholithiasis (though it is for cholecystolithiasis) 2, 7, but positive identification of CBD stones on ultrasound places patients in the high-risk category 1, 5
• CT scanning plays an important role in identifying malignant biliary obstruction but is not routinely used for detecting CBD stones; sensitivity decreases considerably for small stones or those with similar density to bile 1
• ERCP is primarily a therapeutic rather than diagnostic modality, given its 5-10% major complication rate 1, 8, 6

Risk Stratification Algorithm

High-risk patients (proceed directly to ERCP without additional imaging):

• CBD stone positively identified on any imaging 1, 5, 6
• Clinical cholangitis (fever, jaundice, RUQ pain) 1, 4
• Combination of pain, duct dilatation, and jaundice in patient with gallstone history 1
• Total bilirubin >4 mg/dL with dilated CBD 5, 6

Intermediate-risk patients (require MRCP or EUS):

• CBD dilatation with normal liver function tests 1
• Abnormal liver function tests with normal caliber biliary system 1
• Bilirubin 1.8-4 mg/dL 5
• Clinical gallstone pancreatitis 5

Low-risk patients (consider alternative diagnosis):

• Normal ultrasound and normal laboratory values 1

Critical Clinical Pitfalls

• Do not rely on ultrasound alone for diagnosis—it misses many CBD stones that MRCP/EUS will detect 1, 7
• Do not proceed directly to ERCP in intermediate-risk patients—the 5-10% complication rate mandates confirmatory imaging first 1, 6
• Do not assume asymptomatic CBD stones are benign—intervention is warranted even without symptoms due to risk of cholangitis, pancreatitis, and secondary biliary cirrhosis 8, 4
• Elderly patients face substantially higher risks with up to 19% major complication rates and 7.9% mortality from endoscopic sphincterotomy 8, 4